9 research outputs found

    Real-time intravital multiphoton microscopy to visualize focused ultrasound and microbubble treatments to increase blood-brain barrier permeability

    Get PDF
    The blood-brain barrier (BBB) is a key challenge for the successful delivery of drugs to the brain. Ultrasound exposure in the presence of microbubbles has emerged as an effective method to transiently and locally increase the permeability of the BBB, facilitating para- and transcellular transport of drugs across the BBB. Imaging the vasculature during ultrasound-microbubble treatment will provide valuable and novel insights on the mechanisms and dynamics of ultrasound-microbubble treatments in the brain. Here, we present an experimental procedure for intravital multiphoton microscopy using a cranial window aligned with a ring transducer and a 20x objective lens. This set-up enables high spatial and temporal resolution imaging of the brain during ultrasound-microbubble treatments. Optical access to the brain is obtained via an open-skull cranial window. Briefly, a 3-4 mm diameter piece of the skull is removed, and the exposed area of the brain is sealed with a glass coverslip. A 0.82 MHz ring transducer, which is attached to a second glass coverslip, is mounted on top. Agarose (1% w/v) is used between the coverslip of the transducer and the coverslip covering the cranial window to prevent air bubbles, which impede ultrasound propagation. When sterile surgery procedures and anti-inflammatory measures are taken, ultrasound-microbubble treatments and imaging sessions can be performed repeatedly over several weeks. Fluorescent dextran conjugates are injected intravenously to visualize the vasculature and quantify ultrasound-microbubble induced effects (e.g., leakage kinetics, vascular changes). This paper describes the cranial window placement, ring transducer placement, imaging procedure, common troubleshooting steps, as well as advantages and limitations of the method.publishedVersio

    Ultrasound and microbubble treatment for improved delivery of nanomedicine to tumours and the brain

    No full text
    The combined use of ultrasound and intravascular microbubbles, referred to as ultrasound and microbubble treatment, has emerged as a promising technique to enhance delivery of nanomedicine to tumours and the brain. Even though the technique is on its way to the clinic, there are still various aspects to study and optimize to make ultrasound and microbubble treatment even more successful. In this thesis we first investigated if ultrasound and microbubble treatment combined with nanoparticles exhibiting features to increase internalization by tumour cells upon ultrasound-mediated delivery would improve the therapeutic efficacy of the treatment. This was studied by combining ultrasound and microbubble treatment with liposomes coated with an enzymatic cleavable poly(ethylene) glycol (PEG) layer which upon cleaving may increase internalization of the liposomes by tumour cells and may destabilize the liposomal membrane resulting in accelerated drug release. For the enzyme sensitive liposome and the two types of control liposomes, ultrasound and microbubble treatment resulted in enhanced tumour accumulation, improved extravasation and increased tumour penetration depth of the liposomes. The therapeutic efficacy data indicated that the enzymatic feature of the liposome had a positive effect on the therapeutic efficacy, making it an interesting approach to increase the therapeutic efficacy of ultrasound and microbubble treatment. Besides improving drug delivery to tumours, ultrasound and microbubble treatment can also be exploited to increase the permeability of the blood-brain barrier (BBB) by opening of tight junctions, creating endothelial cell openings and stimulating endo- and/or trans-cytosis. To exploit the different ultrasound induced transport pathways to the fullest, a high concentration of drug at the site of BBB disruption is favourable. By combining ultrasound and microbubble treatment with a liposome targeting the transferrin receptor on the BBB, it was investigated if this would enhance delivery of liposomes across the BBB compared to liposomes lacking the BBB-targeting moiety. The combined use resulted in a 40 % increase in accumulation of the BBB targeted liposomes whereas the control liposomes showed no increased accumulation. The results demonstrated that ultrasound and microbubble treatment may enhance endocytosis of the BBB-targeting liposomes which could be an interesting approach to enhance drug delivery to the brain. The potential of Acoustic Cluster Therapy® (ACT), a microbubble platform specifically engineered for therapeutic applications, to increase the permeability of the BBB and enhance delivery of nanomedicine to the brain was also explored. Directly upon ACT, increased BBB permeability was observed and one hour post ACT a 5.2-fold and 3.7-fold increase in accumulation of a model drug and clinically relevant core-crosslinked polymeric micelles (CCPM) was detected, respectively. Confocal microscopy images of the ACT-treated brains verified the improved extravasation and penetration of the CCPM into the brain parenchyma. Histological analysis of brain sections revealed no treatment related tissue damage. With this study we demonstrated that ACT safely and transiently increases the permeability of the BBB and improves accumulation and distribution of nanomedicine to the brain. ACT is expected to work by a different mechanism compared to conventionally used microbubbles such as SonoVue™. An intravital microscopy set-up to unravel the mechanism of action of ACT in the brain was therefore established with help of experienced collaborators. The surgical and technical procedures required to conduct in vivo multiphoton imaging simultaneously with ultrasound and microbubble treatment were described in detail. To summarize, the work presented in this thesis has increased our understanding on how ultrasound and microbubble treatment can be used to improve delivery of nanomedicine to tumours and the brain. Even though there is still a lot to learn, the increasing number of (pre)clinical studies demonstrates that ultrasound and microbubble treatment could impact medicine by enhancing drug delivery and thereby improving and enabling treatment of various cancer types and several brain diseases

    Real-time intravital multiphoton microscopy to visualize focused ultrasound and microbubble treatments to increase blood-brain barrier permeability

    No full text
    The blood-brain barrier (BBB) is a key challenge for the successful delivery of drugs to the brain. Ultrasound exposure in the presence of microbubbles has emerged as an effective method to transiently and locally increase the permeability of the BBB, facilitating para- and transcellular transport of drugs across the BBB. Imaging the vasculature during ultrasound-microbubble treatment will provide valuable and novel insights on the mechanisms and dynamics of ultrasound-microbubble treatments in the brain. Here, we present an experimental procedure for intravital multiphoton microscopy using a cranial window aligned with a ring transducer and a 20x objective lens. This set-up enables high spatial and temporal resolution imaging of the brain during ultrasound-microbubble treatments. Optical access to the brain is obtained via an open-skull cranial window. Briefly, a 3-4 mm diameter piece of the skull is removed, and the exposed area of the brain is sealed with a glass coverslip. A 0.82 MHz ring transducer, which is attached to a second glass coverslip, is mounted on top. Agarose (1% w/v) is used between the coverslip of the transducer and the coverslip covering the cranial window to prevent air bubbles, which impede ultrasound propagation. When sterile surgery procedures and anti-inflammatory measures are taken, ultrasound-microbubble treatments and imaging sessions can be performed repeatedly over several weeks. Fluorescent dextran conjugates are injected intravenously to visualize the vasculature and quantify ultrasound-microbubble induced effects (e.g., leakage kinetics, vascular changes). This paper describes the cranial window placement, ring transducer placement, imaging procedure, common troubleshooting steps, as well as advantages and limitations of the method

    Ultrasound-mediated delivery enhances therapeutic efficacy of MMP sensitive liposomes

    Get PDF
    To improve therapeutic efficacy of nanocarrier drug delivery systems, it is essential to improve their uptake and penetration in tumour tissue, enhance cellular uptake and ensure efficient drug release at the tumour site. Here we introduce a tumour targeting drug delivery system based on the ultrasound-mediated delivery of enzyme sensitive liposomes. These enzyme sensitive liposomes are coated with cleavable poly(ethylene glycol) (PEG) which will be cleaved by two members of the enzyme matrix metalloproteinase family (MMP-2 and MMP-9). Cleavage of the PEG coat can increase cellular uptake and will destabilize the liposomal membrane which can result in accelerated drug release. The main aim of the work was to study the effect of focused ultrasound and microbubbles on the delivery and therapeutic efficacy of the MMP sensitive liposome. The performance of the MMP sensitive liposome was compared to a non-MMP sensitive version and Doxil-like liposomes. In vitro, the cellular uptake and cytotoxicity of the liposomes were studied, while in vivo the effect of ultrasound and microbubbles on the tumour accumulation, biodistribution, microdistribution, and therapeutic efficacy were investigated. For all tested liposomes, ultrasound and microbubble treatment resulted in an improved tumour accumulation, increased extravasation, and increased penetration of the liposomes from blood vessels into the extracellular matrix. Surprisingly, penetration depth was independent of the ultrasound intensity used. Ultrasound-mediated delivery of free doxorubicin and the Doxil-like and MMP sensitive liposome resulted in a significant reduction in tumour volume 28 days post the first treatment and increased median survival. The MMP sensitive liposome showed better therapeutic efficacy than the non-MMP sensitive version indicating that cleaving the PEG-layer is important. However, the Doxil-like liposome outcompeted the MMP and non-MMP sensitive liposome, both with and without the use of ultrasound and microbubbles.publishedVersio

    Focused ultrasound and microbubble treatment increases delivery of transferrin receptor-targeting liposomes to the brain

    No full text
    The blood-brain barrier (BBB) is a major obstacle to treating several brain disorders. Focused ultrasound (FUS) in combination with intravascular microbubbles increases BBB permeability by opening tight junctions, creating endothelial cell openings, improving endocytosis and increasing transcytosis. Here we investigated whether combining FUS and microbubbles with transferrin receptor-targeting liposomes would result in enhanced delivery to the brain of post-natal rats compared with liposomes lacking the BBB-targeting moiety. For all animals, increased BBB permeability was observed after FUS treatment. A 40% increase in accumulation of transferrin receptor-targeting liposomes was observed in the FUS-treated hemisphere, whereas the isotype immunoglobulin G liposomes showed no increased accumulation. Confocal laser scanning microscopy of brain sections revealed that both types of liposomes were mainly observed in endothelial cells in the FUS-treated hemisphere. The results demonstrate that FUS and microbubble treatment combined with BBB-targeting liposomes could be a promising approach to enhance drug delivery to the brain. (E-mail: marieke.olsman@ntnu. no

    Ultrasound-mediated delivery enhances therapeutic efficacy of MMP sensitive liposomes

    No full text
    To improve therapeutic efficacy of nanocarrier drug delivery systems, it is essential to improve their uptake and penetration in tumour tissue, enhance cellular uptake and ensure efficient drug release at the tumour site. Here we introduce a tumour targeting drug delivery system based on the ultrasound-mediated delivery of enzyme sensitive liposomes. These enzyme sensitive liposomes are coated with cleavable poly(ethylene glycol) (PEG) which will be cleaved by two members of the enzyme matrix metalloproteinase family (MMP-2 and MMP-9). Cleavage of the PEG coat can increase cellular uptake and will destabilize the liposomal membrane which can result in accelerated drug release. The main aim of the work was to study the effect of focused ultrasound and microbubbles on the delivery and therapeutic efficacy of the MMP sensitive liposome. The performance of the MMP sensitive liposome was compared to a non-MMP sensitive version and Doxil-like liposomes. In vitro, the cellular uptake and cytotoxicity of the liposomes were studied, while in vivo the effect of ultrasound and microbubbles on the tumour accumulation, biodistribution, microdistribution, and therapeutic efficacy were investigated. For all tested liposomes, ultrasound and microbubble treatment resulted in an improved tumour accumulation, increased extravasation, and increased penetration of the liposomes from blood vessels into the extracellular matrix. Surprisingly, penetration depth was independent of the ultrasound intensity used. Ultrasound-mediated delivery of free doxorubicin and the Doxil-like and MMP sensitive liposome resulted in a significant reduction in tumour volume 28 days post the first treatment and increased median survival. The MMP sensitive liposome showed better therapeutic efficacy than the non-MMP sensitive version indicating that cleaving the PEG-layer is important. However, the Doxil-like liposome outcompeted the MMP and non-MMP sensitive liposome, both with and without the use of ultrasound and microbubbles

    Ultrasound-mediated delivery enhances therapeutic efficacy of MMP sensitive liposomes

    No full text
    To improve therapeutic efficacy of nanocarrier drug delivery systems, it is essential to improve their uptake and penetration in tumour tissue, enhance cellular uptake and ensure efficient drug release at the tumour site. Here we introduce a tumour targeting drug delivery system based on the ultrasound-mediated delivery of enzyme sensitive liposomes. These enzyme sensitive liposomes are coated with cleavable poly(ethylene glycol) (PEG) which will be cleaved by two members of the enzyme matrix metalloproteinase family (MMP-2 and MMP-9). Cleavage of the PEG coat can increase cellular uptake and will destabilize the liposomal membrane which can result in accelerated drug release. The main aim of the work was to study the effect of focused ultrasound and microbubbles on the delivery and therapeutic efficacy of the MMP sensitive liposome. The performance of the MMP sensitive liposome was compared to a non-MMP sensitive version and Doxil-like liposomes. In vitro, the cellular uptake and cytotoxicity of the liposomes were studied, while in vivo the effect of ultrasound and microbubbles on the tumour accumulation, biodistribution, microdistribution, and therapeutic efficacy were investigated. For all tested liposomes, ultrasound and microbubble treatment resulted in an improved tumour accumulation, increased extravasation, and increased penetration of the liposomes from blood vessels into the extracellular matrix. Surprisingly, penetration depth was independent of the ultrasound intensity used. Ultrasound-mediated delivery of free doxorubicin and the Doxil-like and MMP sensitive liposome resulted in a significant reduction in tumour volume 28 days post the first treatment and increased median survival. The MMP sensitive liposome showed better therapeutic efficacy than the non-MMP sensitive version indicating that cleaving the PEG-layer is important. However, the Doxil-like liposome outcompeted the MMP and non-MMP sensitive liposome, both with and without the use of ultrasound and microbubbles
    corecore